Hostname: page-component-8448b6f56d-sxzjt Total loading time: 0 Render date: 2024-04-19T07:12:11.362Z Has data issue: false hasContentIssue false
  • English
  • Français

Paraneoplastic Neuromuscular Disease in Lung Large Cell Neuroendocrine Carcinoma

Published online by Cambridge University Press:  02 December 2014

Roberto Di Fabio ,
Laura Benedetti ,
Konstantinos Michailidis ,
Francesco Pierelli  and
Carlo Casali
Roberto Di Fabio*
Affiliation:
Department of Neurorehabilitation, University of Rome “La Sapienza” - Polo Pontino Latina, Italy
Laura Benedetti
Affiliation:
Department of Neurorehabilitation, University of Rome “La Sapienza” - Polo Pontino Latina, Italy
Konstantinos Michailidis
Affiliation:
Department of Neurorehabilitation, University of Rome “La Sapienza” - Polo Pontino Latina, Italy
Francesco Pierelli
Affiliation:
Department of Neurorehabilitation, University of Rome “La Sapienza” - Polo Pontino Latina, Italy
Carlo Casali
Affiliation:
Department of Neurorehabilitation, University of Rome “La Sapienza” - Polo Pontino Latina, Italy
*
Dipartimento di Neuroriabilitazione, Università di Roma “La Sapienza” - Polo Pontino ICOT - Via Franco Faggiana 34, 04100 Latina, Italia.
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Peer Reviewed Letter
Information
Canadian Journal of Neurological Sciences , Volume 35 , Issue 4 , September 2008 , pp. 516 - 518
Copyright
Copyright © The Canadian Journal of Neurological 2008

References

1. Burns, TM, Juel, VC, Sanders, DB, Phillips, LH 2nd. Neuroendocrine lung tumors and disorders of the neuromuscular junction. Neurology. 1999;52(7):1490–1.Google Scholar
2. Graus, F, Keime-Guibert, F, Rene, R, Benyahia, B, Ribalta, T, Ascaso, C, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain. 2001;124(6):1138–48.Google Scholar
3. Demirer, T, Ravits, J, Aboulafia, D. Myasthenic (Eaton-Lambert) syndrome associated with pulmonary large-cell neuroendocrine carcinoma. South Med J. 1994;87(11):1186–9.Google Scholar
4. Gultekin, SH, Rosenfeld, MR, Voltz, R, Eichen, J, Posner, JB, Dalmau, J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000;123(7):1481–94.CrossRefGoogle ScholarPubMed
5. Alamowitch, S, Graus, F, Uchuya, M, Reñé, R, Bescansa, E, Delattre, JY. Limbic encephalitis and small cell lung cancer. Clinical and immunological features. Brain. 1997;120(6):923–8.Google Scholar
6. Mason, WP, Graus, F, Lang, B, Honnorat, J, Delattre, J-Y, Valldeoriola, F, et al. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain. 1997;120(8):1279–300.Google Scholar
7. Rudnicki, SA, Dalmau, J. Paraneoplastic syndromes of the peripheral nerves. Curr Opin Neurol. 2005;18(5):598–603.Google Scholar
8. Sillevis Smitt, PS, Grefkens, J, de Leeuw, B, van den Bent, M, van Putten, W, Hooijkaas, H, et al. Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy. J Neurol. 2002;249(6):745–53.Google Scholar
9. Lucchinetti, CF, Kimmel, DW, Lennon, VA. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology. 1998;50(3):652–7.Google Scholar
10. Verschuuren, JJ, Perquin, M, ten Velde, G, De Baets, M, Vriesman, PB, Twijnstra, A. Anti-Hu antibody titre and brain metastases before and after treatment for small cell lung cancer. J Neurol Neurosurg Psychiatry. 1999;67(3):353–7.Google Scholar
11. Hiroshima, K, Iyoda, A, Shida, T, Shibuya, K, Iizasa, T, Kishi, H, et al. Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immunohistochemical, and molecular analysis. Mod Path. 2006;19(10):1358–68.Google Scholar
12. Dalmau, J, Gultekin, SH, Voltz, R, Hoard, R, DesChamps, T, Balmaceda, C, et al. Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain. 1999;122(1):27–39.CrossRefGoogle ScholarPubMed
13. Dalmau, J, Graus, F, Villarejo, A, Posner, JB, Blumenthal, D, Thiessen, B, et al. Clinical analysis of anti Ma-2-associated encephalitis. Brain. 2004;127(8):1831–44.CrossRefGoogle ScholarPubMed
14. Ances, BM, Vitaliani, R, Taylor, RA, Liebeskind, DS, Voloschin, A, Houghton, DJ, et al. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain. 2005;128(8):1764–77.Google Scholar